Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues
AssigneeState University of New York
InventorsMonte Blau, Hank F. Kung
Life of this patent
Estimating the term…
Loading patent…
AssigneeState University of New York
InventorsMonte Blau, Hank F. Kung
Estimating the term…
A radiopharmaceutical chemical compound comprising a radioactive isotope, other than an isotope of iodine, in chemical combination with at least one amine group. The compound has a lipophilicity sufficiently high at a pH of 7.6 to permit passage of the compound from the blood of a mammal into a target organ or tissue and sufficiently low at a pH of 6.6 to prevent rapid return of the compound from the target organ or tissue to the blood. The compound has a percent protein binding of less than ninety percent. A method for selectively depositing a radiopharmaceutical compound in at least one target tissue or organ of a mammal, which tissue or organ has a significantly different intracellular pH than the blood of the mammal, by introducing the compound of the invention into the bloodstream of the mammal.
A method for selectively depositing a radiopharmaceutical compound emitting radiation readily observable by radiation detecting means in at least one target tissue or organ of a mammal, the target tissue or organ having a physiologically significantly different intracellular pH than the blood of the mammal, the method comprising the step of:
A radiopharmaceutical method for observing at least one target tissue or organ of a mammal, the target tissue or organ having a physiologically significantly lower intracellular pH than the blood of the mammal, the method comprising the steps of:
Dependencies are inferred from the claim text.